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1.Abstract 
The female athlete triad was defined in 1997 by the American College of Sports 
Medicine (ACSM) consisting of three components: Disordered Eating, Amenorrhea 
and Osteoporosis (Waldrop, 2005). Previous literature has identified a reduced bone 
health in athletes with altered menstrual cycles and/or those with eating disorders. 
For this masters, athletes were recruited from elite athletic databases then grouped 
according to their menstrual cycle irregularities and physical activity levels identified 
from a questionnaire completed prior to participation. The three groups identified 
were controls, eumonrrheic athletes or amenorrheic athletes. Each participant was 
subject to dual energy X-ray absorptiometry (DEXA), peripheral quantitative 
computed tomography (pQCT) scanning, a blood test, if willing, to assess hormonal 
status.  A three day food diary was completed prior to testing. 
Significant differences between both eumenorrehic and amenorheic athletes and 
controls were identified for total calorie, proteins, carbohydrate, potassium and 
phosphorous intake per day. pQCT scanning showed significantly lower cortical 
thickness in the amenorrheic athletes compared with eumenorrheic athletes 
(P=0.025). The amenorrehic athletes had a greater endochondrol circumference  
than both control and eumenorrheic athletes, indicating that the amenorrehic athletes 
had a diaphysis much wider and thinner than the control and eumenorrheic athletes 
(P=0.011). There was a significant difference at the tibia cortical area of the 
diaphysis between the control and amenorrheic athletes (P=0.017). DEXA results 
highlighted significant differences between control and amenorrheic athletes, with 
controls having a greater bone mineral density, at non weight bearing sites of the 
head (P=0.038), trunk (p=0.004), ribs (p=0.027), pelvis (p=0.015), spine (p=0.008) 
and L1-L4 (p=0.025). With further significant differences found between the 
amenorrehic and eumenorrheic group of athletes at the trunk (p=0.020) and pelvis 
(p=0.016), in this case the bone mineral density of the eumenorrheic athletes was 
higher than the amenorrheic athletes. Blood tests demonstrated a significantly higher 
level of the bone resoprtion marker Tartrate resistant- acid phosphatase (TRAP) in 
amenorrheic athletes than in the eumenorrheic and control groups (p=0.026).  
Overall results demonstrate that elite level endurance athletes with amenorrhea have 
lower bone mineral density in the radius and tibia compared with other eumenorrheic 
athletes and controls which was associated with increased circulating levels of 
TRAP. 
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2. Introduction 
2.1 An Overview 
The female athlete triad was defined in 1997 by the American College of Sports 
Medicine (ACSM) consisting of three components: Disordered Eating, Amenorrhea 
and Osteoporosis (Waldrop, 2005). Some studies have shown that the prevalence 
the triad can be as high as 62% of female endurance athletes (Waldrop, 2005; 
Rosen & Hough, 1988).  
Of the three components of the triad, low energy availability seems to be the most 
common.  Rosen et al (1986) demonstrated 32% of his studied female athletes 
practised weight control, of which 70% did not recognise the dangers or harmful 
effects of such behaviours. In another study of 562 female and 832 male athletes, 
13% showed weight control behaviours (Johnson et al., 1999).There were 9.2 % of 
females identified to have had clinically significant problems with bulimia nervosa 
versus 0.1% of the males. There were 2.85% females who had problems with 
anorexia nervosa with zero for males; however, 10.85% females reported binge 
eating on a weekly or greater basis versus 13.02% for males. 5.52% of females 
reported purging behaviour with 2.04% for males, on a weekly or greater basis. 
Similarly 18% of a Norwegian athlete study displayed disordered eating behaviour 
(Johnson et al., 1999). Up to 62% of elite athletes have been shown to portray 
disordered eating with as little as 0.4-4% of the general adolescent population 
practising the weight control behaviours (Nichols et al., 2006). The disordered eating 
component of the triad can be subtle or small at first but can progress to serious 
disorders of anorexia and bulimia nervosa.   
The early stages of the disordered eating habits can initiate a hypothalamic 
amenorrhea, secondary to the athlete’s energy deficit. As many as 79% of the 
female athletes with disordered eating patterns experience a menstrual disturbance 
(Lloyd et al., 1985). This could be either irregular or total absence of menses, where 
a regular menstrual cycle has been defined as menses every 25-35 days or 10-13 
menses/year (Lloyd et al., 1985). Not only inapproporiate eating patterns, but also 
vigorous exercise increases the rates of oligomennorhea and amenorrhea from 5% 
within the sedentary population to as much as 20% of those who regularly exercise 
on a regular basis at a high intensity (Lloyd et al., 1985). There are numerous types 
of specific irregularities that can arise and will be discussed later in the ‘Menstrual 
disturbances’ section. 
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 Amenorrhea is not the only type of menstrual dysfunction associated with the female 
athlete triad. Oligomenorrhea is a shortened luteal phase as well as annovulation, 
cycles with no ovulation, which is also associated with a detriation in bone health 
(Lebrun, 2007). The menstrual disturbances cause hypo-oestrogen levels leading to 
low and inadequate absorption of dietary calcium with a poor incorporation into bone. 
The bone health then suffers as a consequence of the imbalances and can lead to 
osteopenia or early onset osteoporosis (Lebrun and Rumball, 2002). In fact a 
decreased bone density is seen in 10-20% of female athletes (Powell, 2011), but it is 
not clear whether this is exacerbated in female athletes with the traid. 
The individual components of the triad can cause significant morbidity but in 
combination the aspects are extremely detrimental, reducing chances of conceiving 
offspring and increasing the risk of diseases- associated with malnutrition (Lebrun 
and Rumball, 2002). It is therefore important to characterise the progression of the 
triad and impact on the skeletal system. Such work will help to determine the 
underlying causes and to identify novel therapeutic strategies. The focus of the 
present work will be on characterising the bone characteristics of young healthy 
women and athletes at high risk of developing the triad. 
2.2 Bone growth, development, composition and function 
Bone makes up the skeletal system of vertebrates and is capable of adapting 
according to stresses it undergoes (Snell 2008). The vertebrate skeleton is formed 
by two processes; intramembranous ossification and endochondral ossification. 
Intramembranous ossification forms flat bones of the skull, including the calvarium 
and mandible, where mesenchymal stem cells differentiate directly into bone forming 
cells; the osteoblasts (Mackie et al., 2011). The same process is involved in 
increasing the diameter of long bones by addition of new bone at the osteogenic 
front. Endochondral ossification forms the majority of the skeleton in which cartilage 
is replaced by bone tissue. In the 5th week of human development the progenitor 
cells begin to condense and form unmineralised and vascular models of developing 
bones evolving into the mesenchymal cells. The mesenchymal cells then 
differentiate into chondrocytes producing type II collagen, making up components of 
the ECM (extracellular matrix) and proteoglycan aggrecan. These chondrocytes form 
the cartilage anlagen establishing the template of the future skeleton (Newman and 
Wallis 2003; Eerden et al., 2003). Ossification of the cartilage is preceeded by  
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hypertrophy of chondrocytes in the mid shaft of the bone as well as deposition of 
bone via osteoblasts that surround the mid shaft. The primary centre of ossification is 
formed when blood vessels, osteoclast and precursors for bone marrow and 
osteoblasts have invaded the cartilage model (Mackie et al., 2011). Osteoclasts and 
osteoblasts work antagonistically by removing cartilage ECM and depositing bone 
respectively. This results in expansion of the primary ossficiation centre towards the 
ends of the anlagen. In long bones a secondary ossification centre forms at the end 
of the cartilage model (Mackie et al., 2011). The growth plate is situated between the 
primary and secondary centre of ossification and is responsible for the longitudinal 
growth of long bones. 
The growth plate is a highly organised cartilage structure within which chondrocytes 
are arranged into longitudinal columns. At the epiphyseal end the reserve zone 
contains resting chondrocytes that have only a few cells that undergo replication. 
Recently it has been identified that these cells secrete a growth factor morphogen 
that acts on proliferating cells determining their orientation. Subsequently resting 
cells differentiate in a longitudinal direction forming proliferative zone columns of 
chondrocytes (Abad et al., 2002). The pre hypertrophic zone is where the cells then 
enlarge and become spherical before the final differentiation of these cells. This last 
division is associated by a massive increase in cell volume forming the hypertrophic 
zone chondrocytes (Mackie et al., 2011). Hypertrophy is accompanied by an 
increase in intracellular calcium concentration that is vital for vesicle production. 
Vesicles secrete calcium phosphate, hydroxyapatite and matrix metalloproteinases 
(MMPs) which cause mineralisation of the vesicles and the surrounding matrix. 
Hypertrophic chondrocytes produce vascular endothelial growth factor (VEGF) which 
attracts blood vessels from the underlying spongiosum (Eeerden et al., 2003). The 
end fate of hypertrophic cells is under scrutiny but in general it is accepted that 
chondrocytes are subject to death by apoptosis. Skeletal maturity and cessation of 
bone growth arises at puberty when the primary and secondary centres of 
ossification meet and eliminate the growth plate replacing it with bone. This is usually 
linked to alterations in sex hormones (Newman and Wallis 2003).  
 Throughout life, the primary function of bones is to provide attachments for muscle 
tendons and ligaments, protect organs, act as mechanical levers and play a role in 
haematopoiesis (Wilmore & Costil, 2004; Horada & Rodan, 2003).  They also help to 
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maintain calcium levels in the blood as well as supporting the soft tissues. 
Approximately 75% of bone is composed of compact bone mass. 
The inner segment of the bone is made of interconnecting spicules whose 
organization is determined by stresses put through the bone. This type of bone is 
called cancellous bone, also known as trabecular bone, and makes up the remaining 
25% of total bone mass. The structure of this section is adapted  to its function by 
having a larger surface area allowing bone forming and resorbing cells to have 
greater chance to contact the bone surface more frequently  (White & Porterfield, 
2007).The mass of bone is maintained by the balances of action of two types of bone 
cells known as osteoclasts and osteoblasts. Osteoblasts are involved in formation of 
bone whilst osteoclasts are involved in bone resorption. Osteoclasts are derived from 
haemopoietic stem cells. The osteoblast cells are derived from mesenchymal stem 
cells along with stromal and bone lining cells. Bone resorption occurs at a much 
higher rate than does bone formation and so even a small increase, hence an 
imbalance of the action, in osteoclasts could then cause bone loss (Horada & 
Rodan, 2003). Bone resorption by osteoclasts takes just 30 days and the bone 
remodelling cycle takes 4 months (Agerbaek et al., 1991) 
 
 Figure1 : A typical long bone shaft (White & Porterfield, 2007). 
The Haversian system indicated in figure 1 shows how osteoclasts are 
interconnected. The Haversian canals allow movement of the osteoclasts. 
Periosteum is the outer covering of the bone. The lamellae are the layers in which 
the bone is laid down in formation, starting with the outer lamellae, then the 
interstitial lamellae and finally the inner lamellae. The blood vessels provide blood 
supply to the bones and allow haematopoesis to be maintained. The Volkmann’s 
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canal perpendicular to the Haversian canal and interconnect the Haversian canal’s 
with the periosteum as well as further nerve fibres and a blood supply (Miller & 
Kasahara, 2005). 
There are different mechanisms and factors that influence the function of the bone. 
Calcium is needed for normal growth, development and maintenance of the skeleton; 
providing the strength and structure. Ninety-nine percent of the bodies’ calcium is 
found in bone. It is one of the primary bone forming minerals and accounts for 1-2% 
of the adult human body weight (Flyn, 2003). A fall in serum calcium concentration is 
sensed by parathyroid principal cells know as calcium sensing receptors. There is 
then a triggered increased in secretion of parathyroid hormone that stimulates 
resorbtion from the bone’s calcium stores allowing the serum calcium concentration 
to reach normal levels again. Once calcium levels have return to norm a rise in 1,25-
dihydroxyvitamin D levels arise allowing absorption of calcium into the bone (Flyn, 
2003). If the serum calcium levels become too high the hormone calcitonin is 
released from the thyroid gland. Calcitonin inhibits actions of osteoclasts, thus bone 
is no longer resorbed, and serum calcium levels return to normal (Plotkin et al., 
1999). The calcium levels are important to be maintained so no detrimental effects 
occur on the bone, as in the case of low calcium levels. The homeostatic mechanism 
is additionally important as an excess of calcium can lead to vascular calcification. 
This can affect the heart and vasculature, impacting on blood flow around the body 
(Yang et al., 2004).  
 
2.3 Bones adapt to loading 
Bone strength is determined by its mass and density. Forces on the bone stimulate 
bone formation and a reduced load will stimulate bone resorbtion. The physical 
activity level of an individual is therefore an important factor in bone health and a 
vital reason to encourage participation in sport. Regular activity is linked with an 
increase in bone density (Nichols et al., 2007). The proportion of inactive people is 
rising in Western society leading to a growing incidence of bone disease, such as 
osteoporosis (Helge & Kanstup, 2002). Osteoporosis can be defined as ‘2.5 standard 
deviations below the average bone density value for young adults’ (Birch, 2005). It is 
a characterized by low bone mass along with ‘microarchitectural’ deterioration of 
bone tissue that will increase the fragility of the skeleton and therefore increasing the 
likelihood of a fracture (Lebrun, 2007). Osteoporosis results in more than 1.3 million 
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osteoporotic fractures a year with an estimated cost of $13.8 billion in the US alone 
(Deng et al., 2000). 
Besides activity, sex steroids also have an influence on the bone health. The 
hormone oestrogen is considered the main regulator of bone formation and 
resorption (Chiu et al., 1999). Oestrogen tends to reduce the osteoclast activity and 
thereby limits the resorbtion. A low concentration of oestrogen will have a negative 
effect on bone mineral density (Helge & Kanstrup, 2002).  The factors described 
should be kept in positive balance for the bone to remain intact. 
Premenarchal years have been shown to provide a ‘window of opportunity’ (Morris et 
al., 1997). This is a period in time in which bone remodelling and the remodelling 
process respond most strongly to mechanical loading. Exercise induced bone 
modelling is greater in the young skeleton corresponding to a stage of development 
when bone remodelling is most active. At this stage, concentrations of blood 
surrounding the bone are at their highest along with prostaglandins and growth 
hormone (Morris et al., 1997). The remodelling process is likely to be enhanced by 
further increase in oestrogen and testosterone. Morris et al (1997) showed an 
exercise group of premenarchal girls’ accrued 5.5% greater total body BMC, 3.6% 
greater lumbar spine BMD and 10.3% greater femoral neck BMD than the controls. 
The exercise intervention programme incorporated a 30 minute physical activity 
session 3 times per week. The programme included a variety of high impact, 
vigorous aerobic workouts; these were such as modified soccer, step aerobics, 
skipping and weight training. Similar studies in women post menarchal aged 20-25 
reported only 1.3% increase in lumbar spine BMD and no change in femoral neck. 
Similarly, premenopausal women only demonstrated an 0.8% increase in lumbar 
spine in response to a weight training intervention. Even less positive was the finding 
by Rockwell et al (1990) that showed a decrease of 4 % in the lumbar spine in 
response to a 9 month weight training programme. The women in this study were 
premenopausal aged 26.2 years +/- 1.3years with controls being 40.4 years +/- 1.6 
years. None of the women had previously partaken in weight training and all 
ingested a 500mg calcium supplement each day throughout the study. At the post 
pubertal stage bone enhancing factors are less readily available and therefore bone 
remodelling occurs at a lesser rate (Mackelvie et al, 2002).Similar findings have also 
been found in veteran tennis players whereby exercise benefits are limited in 
adulthood due to the cessation of longitudinal skeletal growth (Ermin et al., 2012; 
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Ireland et al., 2014). The benefits of beginning physical activity are twice as great if 
the initial phases of training occur prior to menarche (Kannus et al., 1995; Ireland et 
al., 2014). 
MacKelvie et al (2002) demonstrated a large increase in exercise in prepuberty 
elicits a bigger bone mineral gain over controls implementing exercise interventions 
within distinct maturity groups has provided evidence for the ‘window of oppourtunity’ 
for bone response in early puberty. By having knowledge of this time period it gives 
valid reason for implementing publicly funded exercise programmes to encourage 
young children to participate in activity and reduce the number of those that are less 
active and help to reduce bone disorders of later life (Eliakim and Beyth, 2003). It is 
known that 26% of final adult bone is accumulated during the two years surrounding 
peak bone growth velocity, which approximates the amount of bone lost during post 
menopausal years (MacKelvie et al., 2002; Eliakim and Beyth, 2003). The active 
boys and girls have been shown to accrue 10-40 % more bone in the two years 
during peak bone velocity than inactive children. In pre-pubertal children it has been 
established that the format or specificity of intervention may be less important than 
the magnitude of increase in weight bearing activity. Further demonstrating the 
benefits of exercise in pre puberty, a 5 week prospective endurance training 
programme was implemented causing an increase of around 15-39% of all bone 
formation markers compared to control subjects who had no changes in any of the 
bone markers. This study by Morris et al (1997) previously described further 
highlights the presence of this window of opportunity and its importance to the bone 
health in later life. However, it is important to note that there is not a linear dose- 
response relationship between physical activity and improved BMD as very 
strenuous activity could lead to ‘athletic amenorrhea’ which induces suppression of 
the hypothalamic gonadal axis causing deleterious effects on the bone health and 
positive benefits of weight bearing activity are no longer gained (Eliakim and Beyth, 
2003). During athletic amenorrhea, oestrogen levels are reduced and therefore the 
final post puberty bone mineral density is lowered as peak bone mass is not 
achieved during the critical period of prepuberty. This athletic amenorrhea has been 
linked to the psychological stress of intense training as well as reduction in energy 
availability. It is estimated that a threshold calorie intake of 20-25kcal/kg of lean body 
mass must be met in order for menstrual cycles to occur regularly (Eliakim and 
Beyth, 2003), females below this threshold will have menstrual disturbances. This 
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indicates why some females undergoing the same high intensity physical training 
have no irregularities whereas some may. The factors of nutritional input and 
menstrual disturbances are discussed later. The low energy is further linked to a 
reduction in LH pulsatility and suppression of further hormones such as T3, insulin 
and IGF-1 (Eliakim and Beyth, 2003). 
There are three main factors involved in bone remodelling; i) the hormonal status ii) 
weight bearing and physical activity iii) dietary intake. Athletes that are involved in 
consistent weight bearing activity, when either or both the hormonal and nutritional 
status become compromised may suffer from a reduction in bone mineral density. 
Females at greatest risk tend to be those involved in sports requiring a lean body 
mass or those that are judged for performance, such as gymnastics (Waldrop 2005; 
Nichols et al., 2007). Females involved in endurance sports are more likely to suffer 
from the disordered eating component of the female athlete triad. Generally men 
have a tendency to want to gain muscle mass for their sport in comparison to 
females (Rackoff & Honig, 2006). Within the general population, men exercise for 
fitness reasons only, leading to a positive self esteem and a lower prevalence of 
eating disorders. Women exercise more for a weight control and aesthetic reasons: 
this is more positively associated with eating disturbances (McDonald & Thompson, 
1990). 
 
2.4 Menstrual Cycle and Disturbances 
One of the main factors that play a role in bone health of females involves the 
monthly menstrual cycle. The menstrual cycle is a natural process that occurs each 
month usually starting from the age of 12.8 years old (Wilmore & Costil, 2004). The 
cycles continue until the onset of menopause at around 49-52years old (Gold et al., 
2001). The menstrual cycle is highly dependent on the functioning of the 
hypothalamic pituitary axis. There are two hormones that are mainly involved in the 
regulation of the menstrual cycle and are linked to this axis; lutenizing hormone (LH) 
and follicle stimulating hormone (FSH). LH requires a low rate of release of 
gonadotropin releasing hormones (GnRH), from the hypothalamus, whilst FSH 
responds to a high rate of release of GnRH (White and Porterfield, 2007). The basic 
menstrual cycle can be described in 9 stages. If fertilisation occurs, human chorionic 
gonadotropin will originate and remain for the 9 months of the pregnancy maintaining 
the corpus luteum. If fertilisation does not occur then the corpus luteum will degrade 
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and die due to a decline in progesterone levels. Negative feedback results and a rise 
in FSH levels 2 days before menstruation will occur. This FSH then causes antrial 
follicles to grow releasing oestrogen and inhibin B. The FSH secretion then declines, 
allowing an increased stimulation of the gonadotrophe and thus a rise in LH levels. A 
dominant follicle arises due to the decreased level of FSH. This follicle then 
produces increased amounts of estradiol 17β and inhibin B. The oestrogen 
stimulates a positive feedback response and results in a surge in LH levels mid 
cycle. The ovary will then stop dividing at metaphase of meisosis II. A new corpus 
letueum is derived from mural granulose cells and theca cells. In the LH surge the 
oestrogen levels decline whilst granulose cells secrete inhibin A. After the LH surge 
the oestrogen levels rise again and, combined with progesterone and inhibin A, exert 
a negative feedback on the gonadotrophe. The FSH and LH then return to their 
normal basal levels, bringing the cycle back to the beginning where the corpus 
luteum remains (White & Porterfield, 2007).  
If the menstrual cycles are interrupted then a decline in bone health is one of the 
consequences. Reduction in bone health is usually a feature of post-menopausal 
older age. The peak bone mass is achieved in the first three decades of life and after 
this there is a greater chance for a decrease in bone mass and osteoporotic 
fractures (Nichols et al., 2007). In the elite female athlete the reduction in bone 
strength can be seen to occur at an earlier age associated with menstrual cycle 
disturbances. The disruption will cause depressed levels of oestrogen in the blood, 
which is the essential hormone for normal bone mineralization (Noakes, 2009). In 
athletes a decline in bone health increases the likelihood for bone related injuries. 
There are different types of irregularities of the cycle. Torstviet and Sundgot-Burgen 
(2005) defined eumenorrhoea to be a regular menstrual cycle from 26 to 32 days. 
Luteal phase defects can arise resulting in no ovulation or oligomenorrhea; an 
irregular pattern of cycles (Birch, 2005). Amenorrhea is frequently described as the 
absence of menses for more than three cycles in a row. Primary amenorrhoea was 
defined as the absence of menarche by the age of 16 and secondary as the absence 
of three or more consecutive menstrual cycles after menarche outside of pregnancy, 
the prevalence being 15-66% in athletic women (Lebrun, 2007). Secondary 
amenorrhea is the cessation of menstrual bleeding after menarche has occurred for 
a period of time greater than or equal to 2 months, not due to pregnancy (Drew, 
1961). Finally, oligomenorrhoea are known to be menstrual cycles of 35 days or 
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more and another separate disturbance is a short luteal phase with a menstrual 
cycle of less than 22 days. Collectively these are all classed as menstrual 
disturbances. Oestrogen is one of the sex steroids that regulate bone formation and 
resorption (Chiu et al., 1999). When the menstrual cycles are disturbed so are the 
levels of oestrogen and it has been observed that up 10- 44% of elite female athletes 
demonstrate amenorrhea (Birch, 2005) thus putting bone heath at risk. The 
protective effects of oestrogen are removed when the menses cease and so the 
women become more vulnerable to calcium loss resulting in a decline in BMD. The 
endocrine responses occurring due to menstrual cycle disturbance and low adipose 
tissue can outweigh the possible beneficial effects of physical activity on bone 
health.  The hormone oestrogen is considered the main regulator of bone formation 
and resorption (Chiu et al., 1999). Oestrogen tends to have the effect of reducing the 
osteoclast number and so limiting the resorption of the bone. Oestrogen is vital for 
the closure of the epiphysis in formation of bone (Horada & Rodan, 2003).  It is 
known that a low concentration of oestrogen will have a negative effect on bone 
mineral density (Helge & Kanstrup, 2002).  Further pituitary hormones affected are 
growth hormone, Insulin growth factor-1 as well as triodothyronine, secreted from the 
thyroid gland, together these alterations affect bone mineralisation and therefore the 
development of bone mass (Stafford, 2005).  
Athletic amenorrhea, as previously mentioned, usually presents as secondary 
amenorrhea. In sports that require a lean physique and associated with a high level 
of competition and stress for the mind and body, menarche of an athlete may be 
delayed and is seen as primary amenorrhea. There is no one single factor that 
causes the delayed menarche (Waldrop, 2005). The intense physical activity 
undergone by elite athletes alters the levels of hormones, as does regular physical 
activity. There are numerous components involved with general athletics training, 
such as competition stress, diet and reduction of body fat and production of heat or 
hypoxia. The continued exercise induced hormonal alterations constantly undergone 
by elite females impair production of gonadotropins altering the luteal phase causing 
a deficiency in ovulation (Arena et al., 1995). 
It is suggested that luteal phase defects and amenorrhoea are due to a decrease in 
availability of energy (Birch, 2005).  There is no single nutritional deficiency that is 
linked to the menstrual disturbances associated with elite female runners. Certain 
traits, however, are often demonstrated between fellow athletes these maybe a low 
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fat and protein intake (Noakes, 2009). Weight and Noakes (1987) confirmed 
abnormal eating patterns are most common among competitive runners. In a group 
of American female collegiate runners Rosen et al1986 found that 47% 
demonstrated one or more weight controlling behaviours such as fasting, vomiting or 
taking appetite suppressants. To date the evidence suggests that menstrual 
dysfunction associated with restrictive eating patterns seen in elite female athletes 
originate from a disturbed psyche that underlies both the abnormalities (Noakes, 
2009). Warren (1980) also supported the hypothesis of a negative energy balance 
induced suppression of reproductive function as a consequence of high frequency, 
intense exercise by identifying a close correlation between the onset of menarche 
with a reduction in training volume or during an injury or vacation (Williams et al., 
2001). Further, Bullen et al., (1985) demonstrated that women who adhered to 
strenuous exercise and diet regimens for two menstrual cycles were more likely to 
have menstrual disturbances in comparison to females who only exercised. 
The energy deficit that is often seen in female athletes, also previously highlighted in 
disordered eating section, is known to be linked to a reduction in Luteinizing 
hormone (LH) pulse frequency causing suppression in the release of gonadotropin 
releasing hormones in turn inducing the amenorrhea. The absence of the 
menstruation may also be another way that the body adapts to conserve energy 
(Waldrop, 2005).  The energy imbalance disrupts the hypothalamic pituitary ovarian 
axis hence the reduction in LH release. The underlying mechanism inducing 
menstrual changes remains unclear. There have been links to the levels of leptin that 
may be associated with the menstrual cycle disturbances in elite female athletes. 
Leptin is secreted in proportion to adiposity providing a negative feedback signal in 
the regulation of body weight homeostasis. Gene expression and secretion of leptin 
is also affected by overall energy balance and reproductive hormone levels. In 
normal weight sedentary females an increase in leptin has been observed in the 
luteal phase of the menstrual cycle (Thong et al., 2000). Findings in the study by 
Thong et al., (2000) report lower levels of leptin in amenrroheic and annovulatory 
athletes along with the absence of its diurnal cycle in those that are amenorrheic 
suggesting the menstrual disturbances are linked to leptin levels. A study by Welt et 
al (2004) treated women with hypothalamic ammennorrhea with leptin. This led to 
normalization of levels of reproductive hormones, follicular development and 
menstrual cyclicity, thus demonstrating the importance of leptin. If there is a decline 
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in energy balance in such a way that amenorrhea is reached the overall hormone 
balance is affected. This imbalance is associated with oestrogen and IGF-1 
deficiency which could also contribute to the bone loss associated with amenorrhea. 
Thong et al (2000) further studied a group of females and found lower plasma leptin 
levels in elite athletes than both active women taking the oral contraceptive pill or 
those normally cyclic. Lower body fat can account for the difference in leptin levels 
between elite, cyclic and recreational athletes. In those amenorrhic the plasma leptin 
levels remained lower suggesting there may be reasons other than adiposity that 
account for the lower leptin levels. The suppression of leptin gene expression and 
secretion from adipose tissue in amenorrhic athletes could be a mechanism that is 
triggered by the athletes negative energy balance (Farah et al., 2000). In the study 
by Welt et al (2004) markers of bone formation bone alkaline phosphatase (BAP) 
and osteocalcin both significantly increased after leptin administration.  Insulin levels 
are also significantly lower in elite female athletes that are amenorrheic Insulin is 
released in the postprandial state and acts on cells, including adipocytes, to promote 
glucose uptake and anabolic status. Low insulin levels due to low calorie intake and 
high insulin sensitivity may provide a mechanism in which the adipose tissue will 
detect energy availability and up or down regulate the gene expression for leptin. 
Further studies are needed to finalise the influences that leptin has on reproductive 
hormones and signalling regarding the availability of energy 
Overall, the major influence on menstrual disturbances in elite female athletes is 
their energy balance. The energy input to meet energy demands is vital to remain in 
balance so not to alter hormones levels to a state in which reproductive function is 
lost. If hormone balance is lost, general interbal physiological processes may also be 
diminished. However there is a genetic condition called polycystic ovarian syndrome 
(PCOS) that can also cause the menstrual cycle disturbances commonly seen within 
the female athlete triad. PCOS is the most common endocrinopathy in young 
women, it affects 6-10% of women of reproductive age (Stachenfield & Taylor, 2009; 
Barontini et al., 2001; Tsilchorozidou et al., 2004). Polsen et al., (1988) found 22% of 
just 257 females had PCOS. It can be defined as the association of clinical and/ or 
biochemical evidence of androgen excess with chronic anovulation, in which an 
oocyte is not released from the ovaries (Franks et al., 2005). The consequences of 
PCOS can include irregular menses, along with infertility and recurrent pregnancy 
loss (Stachenfield & Taylor, 2009). These disturbances in the menstrual cycle will 
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once again contribute to a decline in bone health due to the reduction in oestrogen 
that may occur (Chiu et al., 1999). 
In athletes this condition can cause confusion. The diagnosis of PCOS can be 
missed and overlooked for components that revolve around the female athlete triad 
instead (Stachenfield & Taylor, 2009). The regular symptoms associated with PCOS 
are masked by certain levels of exercise making it hard to diagnose in the female 
athlete. One of the main risk factors of PCOS is obesity and female endurance 
athletes are not obese due to their high levels of physical activity. However, only 
50% of women with PCOS are obese, but yet the condition seems to still be under 
diagnosed in women with a low or normal body mass index (Stachenfield & Taylor, 
2009). The syndrome will still cause menstrual disturbances that are interlinked with 
a reduction in bone health. As the condition seems to be overlooked in athletes, this 
will prolong the time period with the menstrual irregularity.  
Noting all these factors that may alter menstrual disturbances it is important that this 
aspect of the female athlete’s physiology should be maintained. 
 
2.5 Disordered eating  
Female athletes are exposed to high psychological pressure relating to the 
expectation to perform to their best. There are also pressures to maintain a very lean 
physique, (with very low fat mass), in the belief it will enhance sporting performance. 
This leads athletes into a negative balance due to high energy expenditure during 
and after exercise and insufficient energy replenishment from food intake and a 
reduction in body weight will result (Raond- Braker et al., 2007). It has been reported 
female runners consume 30% less energy and carbohydrate per kilogram of body 
weight than male runners (Manore et al., 2007: Burket et al., 2001). Evidence 
suggests that women involved in lean sports, such as endurance running, 
gymnastics and cross country skiing, are at a greater risk for disordered eating than 
athletes in non lean sport (Reinking and Alexander, 2005).  
The disordered eating component of the triad not only comprises of anorexia 
nervosa and bulimia nervosa but also a chronic reduction in energy intake through 
dietary restraint, all of which reduce energy availability. Dietary restraint is the most 
common behaviour that is associated with negative bone health (Barrack et al., 
2008). Most females need a minimum of 5-6 g of carbohydrate per kilogram (kg) of 
body weight to maintain the glycogen stores that are needed to support 
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baseline/moderate training (Burket et al., 2004). Fatty acids stored in adipocytes and 
localised lipid droplets as well as glucose stored in liver and muscle glycogen stores 
provide the major sources of exercise fuel.  Glucose sources are more limited in 
comparison to fat stores (Burke et al., 2004). The availability of glucose as a 
substrate for the muscle and central nervous system becomes a limiting factor in the 
performance of endurance sessions equal to or greater than 90 minutes (Burke et 
al., 2004) although higher intensity exercise will have a greater reliance on glucose 
as fuel and will decrease the exercise time that can be sustained by glucose 
metabolism. The use of glycogen stores during exercise will vary depending on 
intensity and duration of the exercise. The required amount will differ between 
trained and sedentary people for any given intensity and duration. In general Manore 
et al (2007) suggest prolonged high intensity exercise will require carbohydrate 
intake of 7-12g per kg of body weight. A significant amount more fibre has been 
found to be consumed by ammenorrheic athletes, this in turn reduces absorption of 
energy and nutrients. Although less data is currently available on protein 
requirements of the female athlete, it is generally advised to consume more protein 
in relation to the recommended daily allowance. In some elite athletes 1.0-1.6 g of 
protein per kg of body weight is needed, in comparison to 0.8 g for non athletic 
populations (Manore et al., 2007). When the energy intakes are low and/ or weight is 
being lost due to energy deficiency, the body will break down tissues, especially 
muscle, to liberate amino acids which can be used to synthesise glucose through 
gluconeogenesis to be used as energy substrates. Fat within diets of active females 
is generally lower than the recommended fat intake of 20-35 % of total energy intake. 
Athletes, particularly endurance trained athletes, have considerably higher fat 
metabolism during exercise compared with untrained people, but the fatty acids are 
not only used for beta-oxidation to make ATP, they also serve numerous metabolic, 
structural and endocrine processes (Manore et al., 2007).  
 Athletes may find themselves in a state of energy deficit unintentionally. The athlete 
may simply maintain the same food habits despite both volume and intensity of 
training increasing. Therefore the result is similar to that of a purposeful weight loss 
programme (Rackoff and Honig, 2006; Waldrop, 2005). In non-athletes, such an 
energy deficit would lead to mainly fat loss, where as the athlete has little fat to lose 
and would therefore degrade muscle mass instead.  Another common behaviour is 
found by the restriction of certain food groups that may be high in fat and/ or protein. 
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As well as harming the bone health, the inadequate input of calories to meet the 
demands of exercise will result in the depletion of muscle glycogen stores, 
hypoglycaemia and electrolyte abnormalities, and consequently impair the physical 
performance of the athlete (Rackoff and Honig, 2006). 
Anorexia athletica is a term that has been identified to distinguish from pathological 
anorexia and is characterised by a reduced energy intake and body mass despite 
high physical performance (Sudi et al., 2004). This category was introduced in the 
early 1990s as athletes constitute a unique population and the symptoms should be 
dealt with differently to non athletes (Sudi et al., 2004). Anorexia athletica presents 
with a specific criteria for diagnosis and is associated with training and sporting 
performance. The criteria, although seen in other people as well, includes 
perfectionism, compulsivness, competitiveness, high self motivation, menstrual 
disturbances along with one unhealthy method of weight control such as fasting, 
vomiting, the use of diet pills, laxatives or diuretics (Birch, 2005). In the category of 
anorexia athletic females clinically indicate a prevalence of 15-60% for disordered 
eating with 50% of these women compulsively over exercising (Birch, 2005).  
Dietary intake that meets the energy demands of the athlete is a necessary 
component that is vital in order for the individual to reach their genetic potential with 
regards to peak bone mass. According to Wang et al (2003) the mid pubertal period 
is the one that is most highly influenced by nutritional input. A calcium intake of 
greater than 1000mg/day was associated with a higher young adult bone mass at 
mid puberty (Wang et al., 2003: Nichols et al., 2007), indicating that an adequate 
dietary intake reaching peak calcium intake allows peak bone mass to be achieved. 
Thus, young girls with sustained energy deficit are less likely to attain a high bone 
mass and may never reach the peak bone mass of their genetic predisposition. 
Thus, the negative energy balance in the teenage years could potentially have life-
long consequences, whereby in early adulthood the increased risk of bone fracture 
could prematurely end the athletic career and in later life a bone fracture can impact 
on confidence and independence in older age (Nichols et al., 2007).  
Further complications may arise from a continued decrease in energy availability for 
the athlete. A hypoglycaemic state is one that will arise as a result of low glucose 
availability (Lebrun, 2007). Continued disordered eating patterns impair athletic 
performance and increase the risk of musculoskeletal injury. Further consequences 
could be depression, fluid and electrolyte imbalance and changes in cardiovascular, 
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endocrine, gastrointestinal and thermoregulatory systems (Lebrun and Rumball, 
2002).  Hypogylcaemia, hypoinsulinemia, hypothyroidism and hypercortisolism may 
all become apparent too. These adaptions could be ways in which the body attempts 
to conserve energy, hence why menses tend to halt (Laughlin and Yen, 1996). 
Longer term issues such as infertility, cardiac abnormalities and osteoporosis could 
ensure, and even result in fatalities (Lebrun and Rumball, 2002).  
 
 
 
 
 
2.6 Bone Health and the Female Athlete Triad 
In the US the number of women in particular who partake in vigorous exercise such 
as running has increased dramatically in the past decade. Now the amount of 
women participating is approximately 7 million with 80% being premenopausal. 
Those who exercise vigorously have an increased rate of amenorrhea of 20% (Lloyd 
et al., 1985). 
In athletes a decline in bone health increases the likelihood for bone related injuries. 
A stress fracture, a common overuse injury, can be defined as the inability of the 
bone to repair itself via osteoblastic remodelling, at the same rate equal to that at 
which repetitive microtrauma is occurring. The osteoclasts work at a faster rate than 
the process of healing eventually leading the bone to fracture (Heyworth & Green, 
2008). Women with a past history of menstrual disturbances are six times more likely 
to develop a stress fracture. The factors causing them are usually linked to low bone 
density, menstrual disturbances and dietary insufficiency along with excessive 
training (Daffner & Pavlov, 1992). In an athlete this will enforce a reduction in loading 
of the bone allowing it to heal and therefore will have implications on training and 
competitions. Overuse injury causes can be divided into 3 categories; training errors, 
such as excessive running intensity or a rapid increase in load, a biomechanical 
issue or anatomical issue. The first of the three can be linked to the female athlete 
triad in which excessive training will lead to an imbalance of hormones and the 
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likelihood to lose weight, due to an increase in training, leaving the bone and body 
susceptible to injury (Geraci and Brain, 2005). Fractures take from 8-12 weeks to 
heal, after which the process of loading again should be slow and gradual (Noakes, 
2009).  
A study involving 2248 female athletes, the 6.4% of endurance runners suffered 
stress injuries, which was a higher frequency than any other sport (Arendt et al., 
2003). One study composing of 53 female and 58 male track and field athletes 
reported an incidence rate of stress fractures of  21.1 % within middle and long 
distance runners with most of their fractures located in the long bones and pelvis 
(Bennell et al., 1996). Women have up to 4 times higher risk for a bone stress injury 
(Lassus et al., 2002). The frequency of occurrence of such bone stress related 
injuries has also been investigated in relation to menstrual cycle irregularities. Using 
x-rays it was documented that 9% of women athletes with a regular menses suffered 
with a fracture whilst the rate was much higher at 24% for those who had absent or 
irregular menses. It was identified that women who had been injured during their 
running programme were more likely to have had or have absent and interrupted 
menses and would be less likely to use the oral contraceptive pill as well as 
participating in the sport for a longer length of time. (Lloyd et al.,1985).  Such a study 
re iterates the importance of regular menses, and therefore can be linked back to the 
female athlete triad whereby the menses are affected by the level of physical activity 
in balance with nutritional input. The decreased oestrogen levels seen in those 
women who exercise frequently is linked to an increased risk of osteoporosis and 
fractures as well as hyperprolactinemia, premature ovarian failure and cessation, all 
documented in premenopausal athletes. 
 
 
 
2.7 Summary of Findings 
Numerous impacting factors can contribute to poor bone health in later life. 
Osteoporosis is a progressive loss of bone mass, primarily due to reduction in bone 
mineral density that mainly affects post-menopausal women. The loss of bone 
mineral density increases the risk of fractures. It is the most frequent bone 
remodelling disease (Takeda et al., 2002). In the United States there are currently 10 
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million people affected by osteoporosis and it is predicted to rise to affect  
approximately 14 million adults who are over the age of 50 by the year 2020 (Lane, 
2005). Osteoporosis and osteoporotic fractures are major causes of morbidity and 
mortality. The National Osteoporosis Foundation has estimated 1.5 million fractures 
a year in the US due to osteoporosis. and it is found that 40-45-% of women aged 
over 50 will suffer an osteoporosis related fracture during their lifetime (Singer, 
2006). At study of 823 caucasian women in their 7th decade revealed 24% had 
osteoporosis in their hip, spine or both, using the criteria defined by the world health 
organisation (Ballard et al., 1998). At the time of this study the annual cost of 
osteoporosis in England and Wales was approximately £742 million. The aetiology of 
osteoporosis is related to the peak bone mass attained during the lifetime usually in 
young adulthood. A person attaining a very high peak bone mass can delay the 
onset of osteoporosis despite progressively losing bone mass in later life. 
Conversely, someone who attains a low peak bone mass in early adulthood will 
more quickly deteriorate to a defined value of low bone mass that is clinically 
significant and, consequently, diagnosed as osteoporosis. Peak bone mass is 
influenced by both genetic and environmental factors (Slemenda et al., 1997), and 
while genetic susceptibility to low or high bone mass is difficult to control, the 
environmental factors can be targeted in an effort to promote skeletal growth.  
Environmental factors could include medication, nutritional status and physical 
activity levels. Physical activity levels and nutrition are easily modifiable and are 
therefore attractive targets. Athletes who engage in repeated, prolonged physical 
activity have been shown to have a 5-30% higher bone mineral density than 
sedentary individuals (Ackerman et al., 2012; Nichols et al., 2007, Wilks et al., 2000; 
Ireland et al., 2011).  This increase in bone mineral density is linked to a 50-80% 
reduction in fracture risk (Nichols et al., 2007). As highlighted at the start of the 
review, there is a ‘window of opportunity’ in which bone is most responsive to 
physical activity (Nichols et al., 2007) which seems to be during adolescence and 
young adulthood with about 90% of peak bone mass being achieved by the age of 
18 years old (Ackerman et al., 2012). During this opportunity the bone is particularly 
responsive to lifestyle factors. During puberty bone mineral mass more than doubles 
in skeletal sites such as the lumbar spine. This peak occurs 2 years later in males 
than females (Rizzoli and Bonjour 1999). An investigation using 156 healthy college 
aged women showed a median gain of bone mass in the third decade (measured as 
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a percentage per decade) 4.8% for the forearm, 5.9% for the lumbar BMC, 6.8% for 
lumbar BMD and 12.5% for total body bone mass.  
It is clear to see that the bone health of female athletes is of major concern. There 
are several environmental factors along with genetic factors that are of such 
influence. There is a very fine line of balance that should be maintained in order for 
the athlete to remain at peak bone health. Pre pubertal stages are a major factor to 
play in the gain of peak bone mass, if this is not achieved to its full potential during 
the ‘window of opportunity’ then this could influence the ability to achieve for the 
athlete in the future. It is important to highlight these factors in order to reiterate the 
necessity of certain interventions are further investigations to help those athletes 
maintain their maximum bone health potential and succeed to their highest 
capabilities. 
Over the years, a number of studies have been conducted into female athletes and 
their bone health. The majority of studies tend to look at separate entities that may 
affect the bone health rather than grouping the female athlete together as a whole 
and conducting an investigation from there. Bennell et al 1996 demonstrated that 
some of the significant risk factors in female athletes for stress fractures are a lower 
bone mineral density and menstrual disturbance history. This study aimed to identify 
specific factors in order for prevention methods to then be implemented. These 
significant factors were only established in females, of the measured variables no 
factors were deemed significant as a risk factor for male athletes. Overall bone 
mineral density was lower in the athletes with stress fractures but still significantly 
higher at the lower limb and of the lumbar spine than non active females. This 
therefore demonstrates some beneficial gains to weight bearing limbs from 
participation in weight bearing activity but overall these gains are lost due to other 
factors being the menstrual cycle disturbances. This leaves an open opportunity of 
research to investigate the comparative weight bearing sites in further detail to see if 
this is representative for other activities and other weight bearing sites. 
Barrow and Saha (1988) identified stress fractures in 49% of their sample of female 
athletes that had very irregular menstrual cycles, 39% in those classed as irregular 
and just 29% had stress fractures with regular cycles. Separately 46% of the 
amenorrheal group, 7% of regular group and 7% of the regular group admitted to an 
eating behaviour disorder. This therefore identified two separate connections to bone 
health in that menstrual cycles could have an impact as well as eating behaviours; 
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leaving the two areas of research to be looked into depth further and whether the two 
can connect together and impact the bone health.  
Mudd et al (2007)identified site specific BMD loss and gains in athletes in different 
sports. Runners had the lowest total body Bone mineral density and site specific 
locations except for the legs, demonstrating some gains are still seen in weight 
bearing limbs of certain activities ie legs in runners. Swimmers and divers were 
shown to have the lowest leg BMD, further showing there are site specific gains in 
BMD. However there are still gaps where research is needed to link the overall lower 
bone mineral density to other components of the triad. This study only focused on 
collegiate level athlete whether there still is a variety of ability. High end elite athletes 
are meant to be at the pinnacle of health, and whether this is demonstrated in their 
bone health is a matter to be investigated. Further studies into site specific gains 
have been shown by Eser et al (2009) who conducted a pQCT study into site 
specific gains of weight bearing activity using retired gymnasts. Specifically the BMC 
(bone mineral content) and CSA (cross-sectional area) were found to be greater at 
the distal radius, as well as muscle CSA showing 15-17.6% greater at the fore arm 
and upper arm of retired gymnasts. The findings showed that the retired athletes 
have site specific skeletal benefits with greater geometric adaption in the upper over 
the lower limbs. Theses site specific gains were identified in retired gymnasts’ 
whether this benefit is still established during full training and competition is yet to be 
highlighted. Here there was little benefit identified in the legs as general controls 
exercise tend to involve some leg impact and so are seen to have some positive 
gains already, whereas gymnasts have the impact in increased use of the forearms.  
Frisch et al (1981) tried to link training patterns to menstrual cycle disturbances 
which then in turn impact the bone health. It was identified ‘Each year of training 
before menarche delayed menarche by 5 months’. Female athletes, runners and 
swimmers, were studied and whether they had started training pre or post menarche 
had an effect on the age of onset of the menstrual cycle. 18 pre menarche trained 
athletes had a mean menarcheal age of 15.1±0.5years whereas 20 post menarcheal 
trained athletes had a menarcheal age of 12.8±0.2years. Pre menarche trained 
athletes; 61% had irregular menstrual cycles with 22% amenorrhea in comparison 
60% post menarche trained athletes had regular cycles with non demonstrating 
amenorrhea. Previously it has been established that a minimum weight for height 
and therefore a critical lean/fat ratio is necessary for menarche and the maintenance 
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of ovulatory cycles. This has been further highlighted from an individual case in 
which an athlete experienced a 2.3kg weight gain which induced menses. The 
athlete began at a height of 169.2cm and mass of 48.9kg which was 2.1kg below the 
stated weight needed to initiate menses. Once the athlete gained the 2.3kg menses 
began whilst continuing to train. After this she in turn lost the weight and menses 
ceased again. This study highlights the fact the high intensity training does have an 
effect on the menstrual cycle, menstrual cycle disturbances increased during training 
in both pre and post menarcheal groups of athletes. If this impact is known to occur 
then there needs to be an implementation in place or an aspect of control to allow 
menses and intense training to occur along side each other maintaining their 
necessary weight for their sport without negatively impacting upon the bone health.  
Further literature has then shown that the together the components of the female 
athlete triad make it a highly prevalent issue amongst young females. Hoch et al 
demonstrated this in 2009; 80 varsity athletes and 50 sedentary controls aged 13-18 
years old were subject to a questionnaire that assessed eating behaviour, menstrual 
status, physical activity whilst also completing a three day food diary ad a serum 
hormonal, TSH and prolactin level test. BMD and body composition was also taken 
using a DEXA scanner. 54% of the athletes demonstrated menstrual irregularities in 
comparison to just 21 % of controls. Overall, 75% of the athletes were found to have 
one or more components of the triad, 65% were identified as the same in control 
group of subjects. This reiterates the high prevalence of the triad amongst female 
athletes but, as well, noting the high percentage still seen in controls; further 
indicating the major importance to prevent the situation within the young female 
population. If the issue is not addressed it leaves open the potential for the majority 
of young females to have a lower bone mineral density, not reaching their optimum 
peak bone mass during development, increasing the likelihood of problems at an 
older age and possibly hindering their athletic career. The affects of the triad on the 
bone health of young females has been further highlighted by Ackerman et al. In 
2011 a group of aged 16-21 years amenhorrhiec athletes, eumenorrheic athletes 
and controls were assessed using DEXA and pQCT. At weight bearing sites the 
athletes tended to have a greater total trabecular area of bone compared to controls. 
However, looking at the bone micro architecture in finer detail it is seen that the 
amenorrhiec athletes had a lower cortical thickness than those eumenorrheic; they 
were also found to have a lowered trabecular number and higher separation. In bone 
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mineral density findings the lumbar spine was lowered in amenorrheic athletes whilst 
eumeonrrheic athletes had the highest BMD at the hip/ femoral neck. The study 
demonstrated the varying affects on the bones from the components of the female 
athletes triad, especially indicating the importance to maintain a regular menstrual 
cycle. In 2012; Ackerman further studied the bone in those eumonorrheic and 
amennorrheic using finite element analysis (FEA); this was conducted using HR-
pQCT to estimate bone strength. Endurance athletes aged 14-21 years old partaking 
in impact sports were analysed. Findings showed that amenorrheic athletes had a 
reduced FEA estimated bone strength at the distal radius and the advantage of 
partaking in weight bearing activity is lost at the tibia compared to the same regions 
in eumenorrheic athletes. Not only is there a high prevalence and a great amount of 
damage that can occur to the bone health of these athletes; the different degrees of 
reduced BMD vary according to the sites whether they are weight bearing or non 
weight bearing. It is known that physical activity is meant to lead to a gain in bone 
mineral density, however when athletes are subject to one or more components of 
the triad, the benefits are somewhat diminished at differing sites of the skeleton. 
Young et al studied a group of 44 female ballet dancers aged approximately 17 
years old, 18 sedentary subjects ammenorheic with anorexia and 23 subjects of 
comparable age with regular cycles. At weight bearing sites BMD is found to be 
normal or elevated in those with a regular menstrual cycle but normal or reduced in 
those with anorexia. Non weight bearing sites demonstrated a reduced BMD in both 
groups. This highlights that some weight bearing activity may be able to offset the 
impact of hypogonadism at weigh bearing sites. At sites with a greater percentage of 
trabecular bone, such as the lumbar spine, there is a severe adverse affect on the 
bone health despite it being an area of high impact. Deficits at non weight bearing 
sites are found to be maintained by body weight. However, the future is not all 
negative as some research has shown that bone health can be restored; one case 
study demonstrated that BMD was able to be regained well into the third decade of 
life by making alterations to body weight and nutrition, as demonstrated by 
Fredericson and Kent (2005). Gains of 25.5% were made in the spin and 19.5% in 
the hip allowing total BMD to reach within normal levels. 
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2.8 Finalisation 
From the literature overview it is clear to see that the female athlete triad has various 
influences upon the bone health of female athletes as well as their hormonal 
functionality, all affecting their potential future athletic career. Prevention at a young 
age is a clear area that needs to be addressed in order to stop such implications 
arising. In order for such a prevention method to be implemented further research 
needs to be conducted to ensure that the preventative method is one in which is sure 
to stop such findings occurring.  
Whilst previous literature has shown to identify differences in BMD and pQCT 
measures of both weight bearing and non weight bearing sites in athletes, no 
literature has introduced the wide variety of contributing factors toward female 
athlete bone health. Research has normally been broken down and just focused on 
one of many possible components. Other literature has also focused on ‘general’ 
athletes or those with a high level of activity, some focus on one sport others group 
into categories such as endurance activities or high impact. All of the groups have 
not used elite level athletes of one kind, tending to use a very wide range of ability, 
most likely due to availability. 
In an ideal world it would be good to be able to group athletes according to whether 
they are within the triad or not. However, to do so three components would need to 
be accurately taken into consideration. Bone health is an objective measure and 
could be done via the DEXA, reporting menstrual cycle history for irregularities is 
also easy to measure via self reporting but there is a potential for bias. The 
nutritional aspect is hard to measure accurately using self reporting along with 
calculating the energy expenditure vs intake. Daily activities can be taken into 
consideration but this would vary again according to basal metabolic rate. 
For this masters study the athletes were grouped according to their menstrual cycle 
irregularities. The nutritional aspect was then looked at as an additional component 
by a three day food diary and assess whether it has a significant impact on the used 
sample.  
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2.9 Aims and objectives 
The main aim of this study is to understand the impact of menstrual irregularities in 
elite female distance runners on bone health. This will be achieved through the 
following objectives: 
1. To recruit female distance runners into the study and characterise the dietary, 
physical activity and hormonal status that are determinants of the female 
athlete triad. 
2. To compare bone characteristics of those amenorrheic and eumenorrheic 
using pQCT to measure tibia and radius bone parameters, DEXA to assess 
total body, lumbar and dual femur bone mineral density. 
3. Biochemical blood markers and VO2max testing were conducted and 
analysed additionally to identify any further possible relationships of those 
athletes with deteriorating bone health 
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3. Materials and Methods 
3.1 Participants 
Female non-athletes, and triad and non-triad elite athletes were recruited. See table 
1 for participant characteristics. Elite athletes in this study are those who ‘participate 
in long term vigorous exercise and training’ and have qualified for a national team at 
the junior or senior level (Torstveit & Sundgot-Birgen, 1994). The elite athletes were 
defined as eumenorrheic or amenorrheic athletes using information gained from 
questionnaire and a food diary. The questionnaires were used to identify menstrual 
cycle disturbances and the food diary to assess the participant’s consumption of the 
daily diet requirements. The food diary was assessed using Diet Plan 6 software 
(see later section for further detail). If the athlete had experienced menstrual 
irregularities either secondary or primary amenorrhea they were classed as 
amenorrheic (AA) if the athletes had regular menstrual cycles over the past year they 
were classed as eumenorrheic (EA). All controls(C) had regular menstrual cycles. All 
women were 18-40 years old. Subjects were recruited through advertising by the 
researchers to known elite female runners and fellow coaches. Non athletic controls 
had a low level of physical activity and did not participate in organized competitive 
team sports.  
3.2 Experimental Protocol 
Height of the subjects was measured on a stadiometer. Body mass was measured 
using electronic scales with the participant in light clothing. 
Training history, past success and achievements and involvement in the sport was 
obtained by a questionnaire (Appendix-food dairy/questionnaire). 
The participants were asked to complete a three day food diary on any three 
consecutive days prior to the testing, specifying both type and amount of food and 
drink consumed. This information was analysed using Diet Plan 6 software 
(Company, Cty, Nation) that calculates the intake of macronutrients and 
micronutrients over the three days and a total calculation for each day.  
Menstrual history was assessed using a questionnaire. Specifically, the participants 
were asked about the phase of cycle at the date of testing, any past irregularities and 
their training loads at this time along with any medication they may be on to help 
regulate their cycles. The questionnaire also contained questions on smoking and 
alcohol consumption.  
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3.3 DXA 
The DXA works on the basis that as x-rays pass through the body. The exiting 
attenuated signal is exponentially related to the path length, tissue density and 
energy of the X-ray. The X-ray source mounted beneath the patient generates a 
narrow tightly collimated beam of X-rays that pass through the patient at rapidly 
switched energies of 70 and 140 kVp (kilovolt peak). The transmitted intensity at 
each energy level is measured by a radiation detector mounted on a C frame directly 
above the X-ray source. During a scan the C arm oscillates rapidly in transverse 
direction while moving slowly longitudinally. The attenuation of the two energy peaks 
by soft tissue is quantified. Results include areal bone mineral density (BMD) (g·cm-
2), which is derived by dividing the bone mineral content by projected area of the 
region that is scanned. DXA reports give the actual values in g·cm-2 as well as T and 
Z scores that reflect the number of standard deviations by which a patient’s value 
differs from the mean of a group of young normal or age and sex matched controls, 
respectively (Lane N 2006-Osteo papers); a Z-score of -2.5 represents a bone mass 
value 2.5 standard deviations (SDs) below the mean of a young healthy adult 
population. 
The bone mineral density was measured at the lumbar spine (L1-L4), and each of 
the two femurs. A whole body scan was taken to determine body fat percentage. For 
a full body DXA the participants lay supine on the scanning bed and were scanned 
from head to toe in approximately 10 minutes. A lumbar spine measure requires the 
patient to lie supine with their legs on a box at a 900 hip angle. The beam was 
aligned approximately 5 cm below their navel and the scan moved in a superior 
direction. The scan of the femurs requires the patient to lie supine with their feet 
strapped either side to a wide triangular box, turning the feet inward, opening the 
hips allowing ease of measure. The beam was aligned to one side just below the line 
of the inferior pubic ramus bone. The scan took a measure of one side and then 
repositioned for the second femur in line with the start position of the first femur 
measure that was taken.  
Scanning the proximal femur also gives measures of the total hip, the femoral neck 
and the trochanter. The lowest value of all tends to be used for diagnostic purposes. 
For this study the average total BMD for the total hip was taken.  
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3.4 pQCT 
Bone characteristics were measured at the non dominant distal radius and dominant 
tibia was assessed using an XCT-2000 pQCT scanner (Stratec Medizintechnik 
GnbH, Pforzheim, Germany). Density and size of the bone measures were taken at 
the epiphyseal site and gross architecture, density and strength and the diaphyseal 
site. Scans were acquired according to manufacturer’s protocols. pQCT scanning 
involves some radiation exposure, each scout and full scan will give a dose of 1 and 
0.9 µSievert, respectively. As we conduct 2 scout scans and 4 full scans this 
comprises a total does of approximately 5.6 µSievert. To put this dosage of radiation 
into context, people in the UK receive around 5 – 6 µSievert of background radiation 
.per day equalling around 2000 µSievert per year, and one hour of jet flight gives 
around 10 µSievert.  Both scan operators have received training on the relevant 
regulations. 
pQCT scans were calibrated with a European forearm phantom. During the study the 
pQCT scanners underwent daily quality assessment. Radius length was measured 
as the distance between the olecraneon process and the radial styloid process. The 
length of the tibia was assessed as the distance between the palpated medial knee 
joint cleft and medial malleolus. To asses epiphyseal and diaphyseal bone 
measures, scans were taken at 4 and 60% of the radius length and 4 and 66% of the 
tibia length, where 0% indicates the most distal part of the respective bones. Data 
were then exported using the Automated Analysis Tools in Version 6.00 of the 
software supplied with the machine. A peeling threshold of 650 mg·cm-3 was set for 
diaphyseal sections of bone, and a threshold of 180 mg·cm-3 set for the epiphyseal 
4% slice. Given the lack of a standard nomenclature for pQCT results, the 
suggestions for reporting bone structure and density results 
(http://www.asbmr.org/StandardizationofBoneStructureandDensityNomenclature.asp
x) and those of a recent publication (25-pQCT methods paper) have been followed. 
The parameters examined in the 4% epiphyseal slice were total bone area (Ar.tot, 
mm2), total bone mineral content (vBMC.tot, mg.mm-1) and trabecular bone mineral 
density (vBMD.tb, mg·cm-3). In diaphyseal sites, Ar.tot, vBMC.tot, cortical area (Ar.ct, 
mm2) and cortical density (vBMD.ct, mg·cm-3) were examined, with adjustments 
made to the cortical density values (due to partial volume effect) by equations 
established in an earlier publication (28-pQCT methods paper). In-vivo precision of 
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the laboratory’s pQCT measurements has been reported elsewhere (26-
pQCTmethods paper) – precision is < 0.5% for vBMC.tot, Ar.tot and Ar.ct.  
 
3.5 Biochemistry Blood Analysis  
Resting 5-mL blood samples were obtained at 12 noon after a minimum of 4 hours of 
fasting, from the antecubital vein. The samples were collected into EDTA collection 
tubes. After half an hour they were centrifuged for 12 min at 2,000 g at 4 0C. The 
plasma was collected and stored at – 80 º Celcius until analysis.  Finger prick blood 
samples were used to measure Haemglobin concentration (Haemocue) and 
haematocrit.   
Estradiol 17-beta- concentration in the blood was measured with ELISA (Abcam, 
UK), following the instructions of the manufacturer. Briefly, 25µL of standard and 
sample were dispensed into their respective wells, and 200µl reagens added. .The 
plate was then covered with foil and incubated at 37ºC for 2 hours. After incubation 
the content of each well was aspirated and washed three times with 300 µL of diluted 
washing solution. Then 100 µL TMB substrate solution was dispensed into all the 
wells. The well of samples was then incubated in the dark at room temperature for 
30 min. After 30 min 100 µL stop solution was dispensed into all the wells and the 
absorbance measured at 450nm. 
Human tartrate-resistant acid phosphatise 5b (TRACP-5b) was measured with 
ELISA (Cusabio biotree co., Ltd) according to the instructions of the manufacturer. 
Briefly, 100 µL of standard and sample were added to each well. An adhesive strip 
was then added to cover the wells and then incubated for 2 hours at 37ºC. After 
incubation period, the liquid of each well was removed and 100 µL of Biotinylated-
antibody pipetted into each well. This was incubated for another hour and then each 
well is aspirated and washed with 200 µL wash buffer. Then 100 µL of HRP-avidin 
was added and incubated for another hour. The wash step was repeated after which 
90 µL TMB substrate was added to each well and incubated for 15-30 mins at 37ºC 
protected from the light. Stop solution (50 µL) was then be added to each well. 
Tapping the plate will ensure thorough mixing. The optical density of each well was 
determined within 5 mins after adding the stop solution. A microplate reader was 
used and absorption measured at 450 nm and 540 nm. The reading at 540 nm was 
subtracted from the reading at 450 nm to correct for optical imperfections in the 
plate. 
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Adrenocorticotrophic hormone (ACTH), Osteoprotegerin (OPG), Osteocalcin (OC), 
Osteoponsin (OPN), Parathyroid hormone (PTH), Fibroblastic growth factor (FGF 
23) and SOST were analysed using EMD Milipore Milliplex human bone magnetic 
bead panel. Briefly, standards were prepared according to instructions of the 
manufacturer. Reagents were warmed to room temperature (20-2 degrees Celsius). 
200 µL of assay buffer was added to each well of the plate. The plate was then 
sealed and mixed on a plate shaker for 10 minutes at room temperature. The assay 
buffer was then decanted ensuring any residual was also removed. Then 25 µL of 
each standard or control was added into their appropriate wells. Then 25 µL of assay 
buffer was added to the sample wells. A further 25 µL of matrix solution was added 
to the background, standard and control wells. 25 µL of 1:2 diluted sample was then 
added into the appropriate wells. Finally 25 µL of mixed beads was then added to 
each well. The plate was then sealed overnight on a plate shaker at 4 ºC. The 
following day the plate was washed 3 times thoroughly.  50 µL of detection 
antibodies were added to each well. The plate was sealed again on a plate shaker 
for 30 minutes at room temperature. 50 µL of Streptavidin-Phycoerythrin was then 
added to each well and then the same previous incubation procedure was followed 
for another 30 minutes. After 30 minutes, the content of each well was removed and 
the pate washed three times. 100 µL of sheath fluid was added to all wells and the 
beads re suspended on the plate shaker for 5 minutes. The plate was then run on 
Luminex 200TM, HTS, FLEXMAP 3DTM or MAGPIX® with xPONENT software and 
the median fluorescent intensity data was analysed using a 5 parameter logistic or 
spline curve-fitting method. 
 
3.6 VO2max 
VO2max was assessed using a standard incremental running treadmill protocol. At 
the end of the treadmill a safety mat was provided. The test lasted approximately 20 
minutes from warm up to cooling down. The heart rate was measured at the end of 
every minute using a polar heart rate monitor. Oxygen and CO2 exchange were 
measured with a Cortex metalyzer.  
The test began with the participant standing on the treadmill breathing as normal to 
collect baseline data. After 2 min the speed of the treadmill was set at 4 km·hr-1 and 
a 0% gradient. After 2 min speed was increased to 8 km·hr-1, still maintaining the 0% 
gradient. After another 2 min speed was increased to 11 km·hr-1 still with the 0% 
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gradient.  After running 2 min at 11 km·hr-1 the speed was finally increased to 15 
km·hr-1 and this speed was maintained for the remainder of the test. The incline on 
the treadmill was increased by 1% every min until the participant was exhausted. 
The participant received verbal encouragement throughout the test.  
 
3.7 Statistical Analysis 
Data were analysed using SPSSv19 (IBM, USA). A one-way ANOVA was used to 
asses any significant differences between control, eumenorrheic athletes and 
amenorrheic athletes. Where data was non-normally distributed, data were 10log 
transformed and a one-way ANOVA done on the transformed data. Differences 
between groups were considered significant at P<0.05. When significance was 
established overall, to then identify where the differences were located between 
groups the Tukey test was conducted which gave the p value for comparison 
between groups. 
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4.Results 
4.1 Participant Characteristics 
 Table 1 shows the participant characteristics. It can be seen that there were no 
significant differences in age, body mass and height between the control, 
amenorrheic athletes (AA) and eumenorrheic athletes (EA). The controls had a 
significantly lower lean mass than the eumenorrheic athletes, but not amenorrheic 
athletes (P=0.017). Fat mass was significantly lower in both amenorrheic and 
eumenorrrheic athletes compared with controls (P<0.0005).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are presented as mean ± SD 
Between brackets n if different from overall 
ª different from C at p˂0.05   
ᵇ different from NT at p˂0.05  
Some athletes volunteered to partake in a VO₂ max test. There was no significant 
difference between VO₂ max results of amenorrheic and eumenorrheic athletes. 
Both eumonrrheic and amenorrheic athletes had an age-graded performance higher 
than 80% for their best ranked running performance, with non significant difference 
between the two groups of athletes. 
 Control (C) Eumenorrheic 
Athletes (EA) 
Amenorrheic 
Athletes (AA) 
n 10 8 7 
Age (Years) 23.5±0.58 24.6±2.39 24.3±1.41 
Height (m) 1.63±0.02 1.67±0.04 1.65±0.02 
Mass (kg) 59.9±2.22 54.9±5.65 50.0±1.93 
Body Mass Index 
(BMI) 
22.4±2.30 19.8±2.01 ª 18.5±1.46 ª 
Lean (kg) 3.78±2.14 4.59±1.72ª 4.31±1.53 
Fat (kg) 19.82±1.71 7.51±0.71ª 4.81±0.74 ª 
%Fat 32.99±8.05 13.68±3.44ª 9.38±3.33ª 
%Lean 63.14±8.76 63.91±9.00 66.29±10.89 ª 
VO₂ 
max(ml-¹kg-¹min-¹)  
n- NT=7 T=4 
 64.4±2.95(7) 64.0±4.86(4) 
Age Graded 
Performance % 
 83.5±9.17 91.0±2.95 
Table 1. Participant characteristics. 
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4.2 DEXA 
In general, the amenorrheic tended to have a lower bone mineral density value in 
comparison with controls and eumenorrheic athletes. Eumenorrheic athletes tended 
to have similar bone mineral density values as controls. Interestingly, no significant 
difference between groups was found in the leg bones, where the runners 
experience direct impact on their bones. 
 
 
 
 
 
 
 
 
 
 
 
Data are mean ± SEM 
ª different from C at p˂0.05   
ᵇ different from NT at p˂0.05  
 
 
  
 Control (C) Eumenorrheic 
Athletes (EA) 
Amenorrheic 
Athletes (AA) 
n 10 8 7 
Head 2.31±0.08 2.30±0.07 1.95±0.09ª 
Left Total 1.16±0.03 1.94±0.02 1.08±0.03 
Right Total 1.16±0.04 1.21±0.02 1.07±0.02 
Arms 0.81±0.02 0.842±0.01 0.765±0.03 
Legs 1.24±0.05 1.35±0.024 1.20±0.04 
Trunk 0.917±0.02 0.898±0.020 0.771±0.02ªᵇ 
Ribs 0.688±0.02 0.664±0.02 0.602±0.01ª 
Pelvis 1.11±0.04 1.11±0.03 0.924±0.03ªᵇ 
Spine 1.06±0.03 1.00±0.03 0.847±0.04ª 
Total Body 1.16±0.03 1.20±0.02 1.07±0.03ᵇ 
Right Femur 
(7) 
1.05±0.06 1.15±0.03 0.924±0.05 
Left Femur (7) 1.05±0.06 1.15±0.03 0.943±0.06 
L1-L4 1.17±0.03 1.15±0.03 0.962±0.05ª 
Table 2: Comparison between athletes and controls for DEXA (g/cm²).  
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4.3 pQCT  
pQCT analysis was carried out at the 4% epiphyseal and 60% of the diaphysis of 
both the non weight bearing radius and weight bearing tibia. At the non weight 
bearing radius there was a significantly lower cortical thickness in the amenorrheic 
athletes compared with eumenorrheic athletes, figure 2a (p=0.025). However, the 
triad athletes had an endochondrol circumference that was greater than both control 
and eumenorrheic athletes, meaning that the amoenorrheic athletes had a diaphysis 
much wider and thinner than the control and eumenorrheic athletes, figure 2b 
(p=0.011). There was also a significant difference at the weight bearing tibia cortical 
area of the diaphysis between the control and amenorrheic athletes but not the 
control and eumenorrheic athletes, shown in figure 2c (p=0.017). For detailed 
definition of pQCT abbreviations see Appendix 7.4. 
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  Control (C) Eumenorrheic 
Athletes (EA) 
Amenorrheic 
Athletes (AA) 
n  10 8 6 
Radius 
Diaphysis 
Ar.tot 
(mm²) 
101.0±3.51 103.0±3.48 108.0±4.46 
 vBMDct 
(mg.mm-
³) 
1185.0±8.3 1192.0±4.76 1152.0±17.30 
 Ar.ct 
(mm²) 
76.0±2.88 80.0±2.28 71.0±4.8 
 Ct.Thder 
(mm) 
2.90±0.12 3.02±0.08 2.47±0.19ᵇ 
 PsC 
(mm) 
36.0±0.62 36.0±0.60 37.0±0.76 
 EcC 
(mm) 
17.3±0.85 17.1±0.76 21.3±1.19ªᵇ 
Radius 
Epiphysis 
vBMC.tot 
(mg.mm-
¹) 
107.0±5.88 116.0±5.76 94.0±2.78 
 vBMD.tb 
(mg.mm-
³) 
196.0±13.30 204.0±16.65 154.0±9.00 
 Ar.tot 
(mm²) 
329.0±16.9 356.0±23.44 359.0±9.67 
Tibia 
Diaphysis 
Ar.tot 
(mm²) 
448.0±22.2 493.0±14.58 526.0±27.76 
 vBMDct 
(mg.mm-
³) 
1182.0±9.57 1176.0±9.29 1155.0±15.38 
 Ar.ct 
(mm²) 
284.6±12.1 334.6±12.43ª 291.6±11.46 
 Ct.Thder 
(mm) 
4.85±0.29 5.60±0.32 4.38±0.31 
 PsC 
(mm) 
74.8±1.77 76.7±1.16 81.1±2.13 
 EcC 
(mm) 
44.3±3.02 44.1±2.64 53.6±3.69 
Tibia 
Epiphysis 
vBMC.tot 
(mg.mm-
¹) 
311.0±16.48 320.0±33.8 317.0±13.7 
 vBMD.tb 
(mg.mm-
³) 
241.0±14.12 257.0±15.3 249.0±11.0 
 Ar.tot 
(mm²) 
986.0±30.29 950.0±89.3 1091.0±22.2 
Table 3: Comparison between athletes and controls for pQCT.  
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 pQCT measurement abbreviations; Ar.tot (mm²) - Total area, vBMDct (mg.mm-³) - 
Cortical bone mineral density, Ar.ct (mm²) - Cortical Area, Ct.Thder (mm ) - Cortical 
Thickness, PsC (mm) - Perichondral circumference, EcC (mm) - Endochondral 
circumference, vBMC.tot (mg.mm-¹) - Total bone mineral content, vBMD.tb (mg.mm-
³) - Trabecular bone mineral density 
 
Data are presented as mean ± SEM 
ª different from C at p˂0.05   
ᵇ different from NT at p˂0.05  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figures 2: Bone measurements form pQCT in athletes and controls. p˂0.05 
C vs NT *, p˂0.05 C vs T **, p˂0.05 T vs NT *** 
 
Figure 2a: Cortical Thickness of Radius 
Diaphyseal Section 
Figure 2b: Endochondral circumference of 
radial Diaphyseal section 
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4.4 Circulating Hormones and bone markers 
In blood samples the following proteins were measured: Oestrogen, Tartrate 
resistant- acid phosphatase (TRAP), Adrenocorticotrophic hormone (ACTH), 
Osteoprotegerin (OPG), Osteocalcin (OC), Osteoponsin (OPN), Parathyroid 
hormone (PTH), Fibroblastic growth factor (FGF 23) and SOST. Groups did not differ 
in any of the analytes, except for TRAP, which was significantly higher in 
amenorrheic athletes compared with control (P=0.026).  
 
 
 
 
  
 
 
 
 
 
 
 
 
 Control (C) Eumenorrheic 
Athletes (EA) 
Amenorrheic 
Athletes (AA) 
n 6 7 6 
TRAP(U/ml) 0.048±0.041 0.074±0.0278 0.43±0.22ª 
Oestrogen 
(pg/ml) 
n- 
C=6, NT=7, 
T=5 
1.545±0.00 (6) 1.545±0.00 (7) 1.545±0.00 
(5) 
ACTH 
(pg/ml) 
2.50±2.50 0.65±0.65 4.65±4.02 
DKK1 (pg/ml) 1215±107 1038±104 865±124 
OPG (pg/ml) 225±27.6 247±23.1 197±15.0 
OC (pg/ml) 12145±1962 12619±825 8471±990 
OPN (pg/ml) 18072.75±2928 26623±3042 19100±3740 
SOST(pg/ml) 3137±598 3107±233 2741±283 
PTH (pg/ml) 85.9±16.8 87.1±12.5 64.8±7.39 
FGF23 
(pg/ml) 
296±195 120±59.0 420±101 
Table 4: Circulating markers of bone remodelling 
Figure 2c: Cortical Area of Tibia Diaphyseal 
Section 
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Data are mean ± SEM 
Between brackets n if different from overall 
ª different from C at p˂0.05   
ᵇ different from NT at p˂0.05  
4.5 Food Intake 
Significant differences between groups were identified for all food groups, except for 
the total calcium intake per day. For total calorie, proteins, carbohydrate, potassium 
and phosphorous intake per day, both groups of athletes consumed higher amounts 
compared with controls but the amenorrheic athletes had a lower intake than the 
eumenorrheic athletes. For total fat and magnesium intake per day, the 
eumenorrheic athletes consumed higher amounts compared with controls. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Control (C) Eumenorrheic 
Athletes (EA) 
Amenorrheic 
Athletes (AA) 
n 8 7 6 
Total Calorie 
Intake/ day  
(kcal·day-1 ) 
1264±166 2725±228.0ª 2382±330ª 
Total Protein/day 
(g·day-1) 
53.9±5.21 95.2±10.67ª 88.8±10.2ª 
Total 
Carbohydrate/day 
(g·day-1) 
168±31.4 437±40.8ª 378±57.5ª 
Total Fat/day 
(g·day-1) 
41.0±7.95 78.0±6.30ª 68.0±11.0 
Total 
Potassium/day 
(mg·day-1) 
2387±334 4132±613.0ª 4385±647ª 
Total 
Calcium/day 
(mg·day-1) 
545±84.0 1403±343.0 1178±140 
Total 
Magnesium/day 
(mg·day-1) 
228±28.0 444±106.0ª 392.0±52.1 
Total 
Phosphorous/day 
(mg·day-1) 
1015±110.0 1822±293ª 1708±185ª 
Table 5: Food intake measurements for athletes and controls 
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Data are shown mean ± SEM  
ª different from C at p˂0.05   
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5.Discussion  
The Female athlete triad is defined as disordered eating, amenorrhea and 
osteoporosis and in some cases has reached up to a prevalence of 62% of female 
athletes (Waldrop, 2005; Rosen & Hough, 1988). The main aim of this study was to 
examine total body bone mineral density and to examine in closer detail the radial 
and tibial bone characteristics of elite female endurance runners with, and without, 
menstrual irregularities. The results showed that amenorrhoeic athletes (AA) had 
lower bone mineral density in the lumbar spine, pelvis, ribs, trunk and head 
compared with age-matched non-athletic young women. Compared with 
eumenorrhoeic athletes (EA), the AA had lower bone mineral density of the total 
body, pelvis and trunk. The data from pQCT showed the endochondrial 
circumference of the radius diaphysis to be higher in AA compared with controls and 
EA, while the cortical thickness of the radius diaphysis was smaller in AA compared 
with EA. The bone differences of AA were accompanied by elevated circulating 
levels of TRAP. 
Previous literature has identified the influence of different components, individually, 
upon the female athlete triad. In general, the female athletes train to a high level 
succumbing their bone to a lot of strenuous exercise. This causes an imbalance of 
hormones in turn having a negative impact on their menstrual cycle. This alteration 
of hormone balance then influences the bone health where net bone resorption 
occurs. 
More and more female athletes suffer from the female athlete triad as the up and 
coming generations arise. The way in which the problem can be counteracted is 
going to be prevention. This prevention could involve exercise or supplementation 
intervention or simply better and more education programmes involving governing 
bodies that can provide a monitoring system for their vulnerable athletes from a 
young age. This education is a vital necessity that must be informed and this study 
has been a step toward getting that informed information. For the masters study we 
chose to group the elite athletes according to their menstrual cycle irregularities, as 
this is a major problem and influence on the bone health, and measured their bone 
characteristics using pQCT and DEXA as well as looking at the other components 
and influences of the triad as separate measures of the individual groups of athletes. 
The other components are nutritional input, hormonal balance via blood draw and 
general bodily characteristics. By conducting such comparisons, differences between 
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the athletes can be detected with findings from previous literature using general 
athletes rather than elite and identify where the balance seems to be lost. 
The main observation of this study was that elite level endurance athletes with 
amenorrhea had lower bone mineral density compared with eumenorrheic athletes 
and controls. This was seen in both the radius and the tibia and was associated with 
increased circulating levels of TRAP. 
Numerous bone health parameters were measured to get an overall impression of 
the possible effects of amenorrhoeia on bone health. pQCT scanning was carried out 
at 4% and 60% of the non dominant non weight bearing radius and the dominant 
weight bearing tibia. At the non weight bearing radius the amenorrheic athletes had a 
significantly lower cortical thickness than eumenorrheic athletes (P=0.025). However, 
the amenorrheic athletes had an endochondrol circumference that was greater than 
both control and eumenorrheic athletes, meaning that the amenorrheic athletes had 
a diaphysis much wider and thinner than the control and eumenorrheic athletes 
(P=0.011). Statistical analysis also demonstrated a significant difference at the 
weight bearing tibia, the cortical area of the diaphysis between the control and 
amenorrheic athletes but not the control and eumenorrheic athetes, (P=0.017). 
These observations confirm previous findings, already highlighted, that demonstrate 
the detrimental effects on the bone health from menstrual cycle irregularities and 
components of the female athlete triad. Our findings, demonstrate that the 
amenorrheic athletes do experience some bone benefits from the impact of their 
physical activity in the lower limbs. Although compromised, lower bone health in AA 
than EA, AA have a better bone health than controls indicating some benefit of 
impact exercise. In the upper limbs, where little loading occurs, they have a lower 
bone strength which could be pinpointed to their potential lack of nutrition or their 
hormonal status. Other studies using pQCT have demonstrated similar findings. 
Ackerman et al (2011) studied a group of aged 16-21 years amenhorrhiec athletes, 
eumenorrheic athletes and controls were assed using DEXA and pQCT. At weight 
bearing sites the athletes tended to have a greater total trabecular area of bone 
compared to controls. However, looking at the bone micro architecture in finer detail 
it is seen that the amenorrhiec athletes had a lower cortical thickness than those 
eumenorrheic; they were also found to have a lowered trabecular number and higher 
separation. These findings agree with what we have demonstrated in this study, that 
those athletes with amenorrhea or have components of the triad show a deterioration 
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in bone health at non weight bearing sites, such as pQCT findings of the radius, 
despite high levels of physical activity.  
DEXA results also support this finding; showing that the amenorrheic athletes have a 
reduction in bone health in comparison to the gains shown by eumenorrehic athletes 
over controls. The limitation on significant findings is due to the limited numbers. 
DEXA revealed significant findings that demonstrated that amenorrehic athletes 
tended to portray a lower bone mineral density in comparison with controls than the 
eumenorrheic athletes. Interestingly, these significant findings were not on the direct 
weight bearing areas in elite runners such as the legs. Thus, suggesting that, even 
though the athlete is within the triad, not all the positive effects are lost from their 
impact through physical activity to the bone at the weight bearing sites. Previous 
studies by Young et al (1994) using ballet dancers demonstrated that at weight 
bearing sites the BMD is found to be normal or elevated in those with a regular 
menstrual cycle (similar to the non triad athletes in this study) but normal or reduced 
in those with anorexia (similar to the triad athletes). However, from table 2 it is clear 
to see that there is a clear pattern that is followed, in all cases the BMD value of the 
EA is at the same level or in most cases elevated in comparison to controls, in all 
cases the AA BMD values are less than both the control group and non triad 
athletes. The limited significant findings could be linked with the varied numbers in 
groups and the small overall sample size, which is invariably a limitation in studies of 
elite-level athletes.  
 TRAP is a marker for increased bone resorption and may provide a mechanistic 
insight to explain the reduced  bone mineral density of AA measured from the DEXA 
and pQCT. Amenorrheic athletes had levels of 0.43 U/ml with controls just 0.048 
U/ml and eumenorrheic athletes 0.074 U/ml; thus demonstrating a much higher level 
of TRAP in the amenorrheic athletes. This result further follows the similar pattern of 
previous findings (REF). However, no significant findings were found in any of the 
other markers of bone remodelling in this study. This may be due to the high inter-
individual variability of the markers for each hormone or due to the fact that the low 
sample size was not enough to identify significant differences. TRAP has not 
regularly been examined in elite athletes of such young age as it is normally used to 
identify bone resorption in the diagnosis of osteoporosis (Bikle, 1997; Garnero and 
Dalmas, 1997). Biochemical analysis of TRAP has also been progressed to use as 
an early identification of rheumatoid arthritis (Garnero et al., 2002). Our results 
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suggest TRAP maybe a marker in young females for susceptibility or detection of the 
triad. This then may help to initiate early interventions to rectify bone health while the 
athlete has not reached the end of the ‘window of opportunity’ in terms of bone 
health. 
Interestingly, PTH showed a similar, though inverse, pattern to TRAP, although it did 
not reach significance; Amenorrheic athletes demonstrate the lowest level of PTH at 
64.8±7.39pg/ml, controls and eumenorrheic athletes have similar levels at 
85.9±16.8pg/ml and 87.1±12.5pg/ml, respectively. PTH hormone regulates calcium 
levels in the blood and is high when calcium levels in the blood are low. The lower 
levels of PTH in the blood could indicate that the response mechanism of the 
eumenorrheic athletes is altered due to their hormonal menstrual status and so 
cannot respond to lower levels of calcium appropriately and therefore the 
consequence will be resorption of the bone to restore correct levels of calcium. 
Osteocalcin measures also demonstrate a pattern supporting the findings of this 
study. Osteocalcin is a marker found where bone building arises by the action of 
osteoblasts. The amenorrheic values are much lower than both the eumenorrheic 
and controls in this case, although not significant; it may indicate a tendency for bone 
resorption arising in AA.  
Finally from the food diary a number of significant differences were identified 
between groupings. For total Calorie, proteins, carbohydrate, potassium and 
phosphorous intake per day a significant difference was found between the both 
groups of athletes and the control groups, as demonstrated by table 5. In each case 
both the amenorrheic and eumenorrheic athletes had a larger intake than controls, 
however, the total calorie intake of the controls was only 1264 ± 166 kCal/day, which 
is considerably lower than the expected total calorie intake of healthy young women 
and raises the possibility of under-reporting of food intake by the control group. For 
total fat and magnesium intake per day there was only a significant difference 
between the eumenorrheic athletes and control group, with the eumenorrheic 
athletes consuming a greater amount. The food diary findings do not show a direct 
link to the bone health as did the DEXA, pQCT and TRAP bone marker result, 
however, it does suggest a further possible factor that may contribute to the bone 
health of the athlete. In each case reported the amenorrheic athlete consumed less 
than that of the eumenorrheic athlete, In all cases the AA and EA consumed more 
than controls but the AA eating less than EA. These findings combined with bone 
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characteristic results would suggest the AA would be in a state of energy deficit. 
However, the use of food diaries does entail the risk of misreporting as shown by 
Posluna et al (2009). In the case there were some abnormal readings, one from 
each group of which were omitted from analysis and all analysis was carried out 
using the same procedure and software eliminating as far as possible bias due to 
wrong reporting and subjective analysis. Again there was still a small sample size 
and ideally larger numbers of participants are needed to ensure findings are 
consistent. A further limitation is that food diaries only reveal half the picture for 
energy balance, the other half coming from energy expenditure.  In this study, it was 
not possible to monitor habitual energy expenditure so we cannot conclude on 
whether any of the groups were in a negative energy state. 
The main limitation of the present study was the small sample size. Small sample 
sizes are inherent in studies of elite athletes.  Furthermore, the main interest in this 
study was to examine differences between triad athletes and non-triad, however, it 
was not possible to make such grouping distinctions a-priori because food intake and 
bone density needed to be measured during the testing session. Thus, groupings 
were made on the menstrual status.  
Overall the findings from this study suggest elite female endurance athletes who 
report menstrual cycle disturbances were significantly more likely to have lower bone 
mineral density in several sites across their body as well as elevated levels of TRAP 
which indicate greater resorption. Further studies should be conducted on a greater 
scale that will aid in the understanding if the female athlete triad and then in turn 
highlight areas that can be targeted as an approach for early intervention and 
possible areas that can be studied for therapies that might limit the triad from 
establishing itself initially. 
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7.Appendix 
 
7.1 Food diary 
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7.2 Patient Information Sheet and Questionnaire 
Training and Menstrual history 
Participant Surname:  
 
Participant First Name: 
 
Participant ID: 
Gender: D.O.B.: Height: 
Weight: Contact email address: 
 
Training 
At what age did you first begin to partake in endurance running at an elite level? 
 
 
 
 
Please list some of the highest level achievements that you have reached since 
starting elite endurance running and at what age these were achieved? 
 
 
 
 
 
 
How many times would you compete on average in one month? 
 
 
 
In brief please could you provide an outline of your weekly training? Not only include 
running but anything additional such as cross training/ gym work/drills etc and how 
long each one would normally take. 
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Please see the example below: 
Day AM PM 
Monday Run 50 mins 
Gym work 1 hour 
20 min run  
Rehab 20 mins 
Tuesday Running session lasting 
about 2 hours in total 
 
Wednesday As Monday  
Thursday Running session lasting 
about 2 hours in total 
 
Friday 20 min run 1 hour gym 
work 
 
Saturday Running session lasting 
about 2 hours in total 
 
Sunday Long run 60-90 mins 45 min gym work 
 
 
Day AM PM 
Monday 
 
 
 
 
  
Tuesday 
 
 
 
 
  
Wednesday 
 
 
 
 
  
Thursday 
 
 
 
 
  
Friday 
 
 
 
 
  
Saturday 
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Sunday 
 
 
 
  
 
Menstrual History: 
At what age(including months), if any, did you first begin menstruating? 
If not begun menstruation please state 
 
 
 
 
Are you taking any medication to help regulate your menstrual cycle such as the oral 
contraceptive pill? Please state if so and briefly state when you started to take the 
medication. (Please state if taking the pill for other reasons and when started to take) 
 
 
 
 
 
 
 
Has there since been any disruption to your regular cycle? If so please can you state 
approximately when this occurred and how long it lasted?  Please list all disruptions 
if multiple. 
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Menstrual cycle Irregularities Summary to be filled in: 
Time of 
Irregularity e.g. 
Feb 2001 
How long 
irregularity 
lasted? Or is it 
still ongoing? 
Training load at 
time of 
irregularity? 
Any other info 
that may be 
linked? Change in 
environment/ 
eating habits etc? 
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At what stage of your menstrual cycle are you today? And what date was the start 
and end of your last menstrual cycle? 
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Do you smoke? (please circle) 
 YES 
 NO 
If yes how many on average per week do you smoke? 
Do you consume alcohol? (please circle) 
 YES 
 NO 
If so please state the frequency that suits you the best (please circle) 
 Everyday 
 2-3 times per week 
 Monthly 
 Odd occasion 
Please state any other relevant info that you may think will be helpful: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
68 
 
7.3 Patient Information Sheet and Questionnaire- Control 
Training and Menstrual history 
Participant Surname:  
 
Participant First Name: 
 
Participant ID: 
Gender: D.O.B.: Height: 
Weight: Contact email address: 
 
Exercise 
Do you partake in any physical activity? If so please state the type. 
 
 
 
 
Please list if any the amount of physical activity you would partake in on average in a 
week. 
 
 
 
 
 
 
In brief please could you provide an outline of you usual week including work/ 
exercise/social and timings etc 
Please see the example below: 
Day AM PM 
Monday University work 20 min run  
Rehab 20 mins 
Tuesday Work 9-5 Aerobics 30 min 
Wednesday Work 9-5  
Thursday University 30 min cycle 
Friday Rest   
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Saturday  Out at night for 3 course 
meal and drinks 
Sunday rest 45 min gym work 
 
 
Day AM PM 
Monday 
 
 
 
 
  
Tuesday 
 
 
 
 
  
Wednesday 
 
 
 
 
  
Thursday 
 
 
 
 
  
Friday 
 
 
 
 
  
Saturday 
 
 
 
 
  
Sunday 
 
 
 
  
 
Menstrual History: 
At what age(including months), if any, did you first begin menstruating? 
If not begun menstruation please state 
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Are you taking any medication to help regulate your menstrual cycle such as the oral 
contraceptive pill? Please state if so and briefly state when you started to take the 
medication. (Please state if taking the pill for other reasons and when started to take) 
 
 
 
 
 
 
 
 
Has there since been any disruption to your regular cycle? If so please can you state 
approximately when this occurred and how long it lasted?  Please list all disruptions 
if multiple. 
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Menstrual cycle Irregularities Summary to be filled in: 
Time of 
Irregularity e.g. 
Feb 2001 
How long 
irregularity 
lasted? Or is it 
still ongoing? 
Training load at 
time of 
irregularity? 
Any other info 
that may be 
linked? Change in 
environment/ 
eating habits etc? 
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At what stage of your menstrual cycle are you today? And what date was the start 
and end of your last menstrual cycle? 
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Do you smoke? (please circle) 
 YES 
 NO 
If yes how many on average per week do you smoke? 
Do you consume alcohol? (please circle) 
 YES 
 NO 
If so please state the frequency that suits you the best (please circle) 
 Everyday 
 2-3 times per week 
 Monthly 
 Odd occasion 
Please state any other relevant info that you may think will be helpful: 
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